These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6775952)

  • 21. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Ewerth S; Nilsell K; Reihnér E; Einarsson K
    Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of ursodeoxycholic acid in man.
    Fedorowski T; Salen G; Calallilo A; Tint GS; Mosbach EH; Hall JC
    Gastroenterology; 1977 Nov; 73(5):1131-7. PubMed ID: 908492
    [No Abstract]   [Full Text] [Related]  

  • 25. Bile lipid secretion in obese and non-obese individuals with and without gallstones.
    Reuben A; Maton PN; Murphy GM; Dowling RH
    Clin Sci (Lond); 1985 Jul; 69(1):71-9. PubMed ID: 4064557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary cholesterol affects chenodeoxycholic acid action on biliary lipids.
    Coyne MJ; Bonorris GG; Chung A; Cove H; Schoenfield LJ
    Gastroenterology; 1977 May; 72(5 Pt 1):927-31. PubMed ID: 849824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
    Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
    J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 29. Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.
    Bazzoli F; Fromm H; Roda A; Tunuguntla AK; Roda E; Barbara L; Amin P
    Dig Dis Sci; 1985 Jul; 30(7):650-4. PubMed ID: 4006647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of low-dose and intermittent chenodeoxycholic acid therapy of gallstones.
    Marks JW; Bonorris GG; Chung A; Coyne MJ; Okun R; Lachin JM; Schoenfield LJ
    Am J Dig Dis; 1977 Oct; 22(10):856-60. PubMed ID: 920688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 7-Methyl bile acids: effects of chenodeoxycholic acid, cholic acid, and their 7 beta-methyl analogues on the formation of cholesterol gallstones in the prairie dog.
    Matoba N; Cohen BI; Mosbach EH; Stenger RJ; Kuroki S; Une M; McSherry CK
    Gastroenterology; 1989 Jan; 96(1):178-85. PubMed ID: 2909419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Conservative treatment of cholelithiasis with chenodeoxycholic and ursodeoxycholic acid preparations].
    Golochevskaia VS; Genia LP
    Klin Med (Mosk); 1992; 70(7-8):60-3. PubMed ID: 1460833
    [No Abstract]   [Full Text] [Related]  

  • 33. Chenodeoxycholic acid therapy of gallstones.
    Dowling RH
    Clin Gastroenterol; 1977 Jan; 6(1):141-63. PubMed ID: 330046
    [No Abstract]   [Full Text] [Related]  

  • 34. Sounding Board. An optimistic view of the National Cooperative Gallstone Study.
    Palmer RH; Carey MC
    N Engl J Med; 1982 May; 306(19):1171-4. PubMed ID: 7040960
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis].
    Garrido G; Bretó M; Pérez F; Berenguer J
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):31-6. PubMed ID: 6635274
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of chenodeoxycholic acid and its conjugates on cholesterol gallstone dissolution in hamsters.
    Kajiyama G; Mizuno T; Yamada K; Maruhashi A; Matsuura C; Kawamoto T; Kubota S; Miyoshi A
    G E N; 1976; 31(1-2):39-47. PubMed ID: 829878
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in bile and blood lipid levels following chenodeoxycholic acid therapy].
    Barbara L; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Sorci F; Roda E
    Minerva Med; 1977 Sep; 68(43):3023-6. PubMed ID: 909650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.
    Iser JH; Sali A
    Drugs; 1981 Feb; 21(2):90-119. PubMed ID: 7009140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chenodeoxycholic acid in the dissolution of gallstones.
    Nutr Rev; 1976 Jan; 34(1):20-1. PubMed ID: 814508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.